ArticleJournal of molecular modeling2020

Designing a new bispecific tandem single-chain variable fragment antibody against tumor necrosis factor-α and interleukin-23 using in silico studies for the treatment of rheumatoid arthritis.

A Barkhordari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.